Tokyo Tape
Sign in
← Trans Genic

Quarterly report · Q3

2342.TEDINET S100STDC
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥9.7bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥11.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥8.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥52m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥153m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥51m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥199m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥385m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥7m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥344m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥38m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥410m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥182m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥43m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥171m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥10.4bnat 2023-12-31Cons.Assets
Total assets¥10.7bnat 2023-03-31Cons.Assets
Total assets¥10.9bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥4.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥4.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥6.0bnat 2023-12-31Cons.Net assets
Net assets / equity¥6.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥6.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-2.272023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.152023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-24.322022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.812022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.542022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio56.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥5m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥450,000
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥5m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥152m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.6bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.6bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥5m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥109m
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥8.1bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥8.1bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥760,000
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥313m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥5m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥204m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥4m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥157m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5m
jpcrp040300-q3r_E05317-000Drug Discovery Support Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥132m
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥1m
jpcrp040300-q3r_E05317-000Investments And Consulting Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥179m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥6m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥310m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 361
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member105400
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0062
Number of shares held in own name treasury shares etcCurrentQuarterInstant105400
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant105400
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0062
Cash and depositsPrior1YearInstant3459447000JPY
Cash and depositsCurrentQuarterInstant2777168000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant1083456000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant1319058000JPY
Merchandise and finished goodsPrior1YearInstant1353059000JPY
Merchandise and finished goodsCurrentQuarterInstant1788425000JPY
Work in processPrior1YearInstant745490000JPY
Work in processCurrentQuarterInstant666354000JPY
Raw materials and suppliesPrior1YearInstant139723000JPY
Raw materials and suppliesCurrentQuarterInstant138612000JPY
Other caPrior1YearInstant788761000JPY
Other caCurrentQuarterInstant498552000JPY
Allowance for doubtful accounts caPrior1YearInstant-7566000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-8018000JPY
Current assetsPrior1YearInstant7562372000JPY
Current assetsCurrentQuarterInstant7180154000JPY
Buildings and structures netPrior1YearInstant980931000JPY
Buildings and structures netCurrentQuarterInstant1020025000JPY
LandPrior1YearInstant905846000JPY
LandCurrentQuarterInstant896676000JPY
Other net ppePrior1YearInstant104883000JPY
Other net ppeCurrentQuarterInstant165607000JPY
Property plant and equipmentPrior1YearInstant1991661000JPY
Property plant and equipmentCurrentQuarterInstant2082309000JPY
GoodwillPrior1YearInstant557250000JPY
GoodwillCurrentQuarterInstant523528000JPY
Other iaPrior1YearInstant10422000JPY
Other iaCurrentQuarterInstant12147000JPY
Intangible assetsPrior1YearInstant567673000JPY
Intangible assetsCurrentQuarterInstant535676000JPY
Investment securitiesPrior1YearInstant105502000JPY
Investment securitiesCurrentQuarterInstant121070000JPY
Other ioaPrior1YearInstant469281000JPY
Other ioaCurrentQuarterInstant462181000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-23559000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-26703000JPY
Investments and other assetsPrior1YearInstant551223000JPY
Investments and other assetsCurrentQuarterInstant556548000JPY
Noncurrent assetsPrior1YearInstant3110559000JPY
Noncurrent assetsCurrentQuarterInstant3174534000JPY
AssetsPrior1YearInstant10672931000JPY
AssetsCurrentQuarterInstant10354689000JPY
Accounts payable tradePrior1YearInstant408742000JPY
Accounts payable tradeCurrentQuarterInstant528426000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass